wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q45800216-12FC8ADF-49A4-4E7E-8364-2CE6406770F3
Q45800216-12FC8ADF-49A4-4E7E-8364-2CE6406770F3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45800216-12FC8ADF-49A4-4E7E-8364-2CE6406770F3
Incidence and risk of regorafenib-induced hepatotoxicity.
P2860
Q45800216-12FC8ADF-49A4-4E7E-8364-2CE6406770F3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45800216-12FC8ADF-49A4-4E7E-8364-2CE6406770F3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9bdb7eaaf364f0bad2b666129108cbf7ba5a346a
P2860
Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial.